The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Fibroblast-Specific Genetic Manipulation of p38 Mitogen-Activated Protein Kinase In Vivo Reveals Its Central Regulatory Role in Fibrosis
Open accessAbstract
Background: In the heart, acute injury induces a fibrotic healing response that generates collagen-rich scarring that is at first protective but if inappropriately sustained can worsen heart disease. The fibrotic process is initiated by cytokines, neuroendocrine effectors, and mechanical strain that promote resident fibroblast differentiation into contractile and extracellular matrix–producing myofibroblasts. The mitogen-activated protein kinase p38α ( Mapk14 gene) is known to influence the cardiac injury response, but its direct role in orchestrating programmed fibroblast differentiation and fibrosis in vivo is unknown. Methods: A conditional Mapk14 allele was used to delete the p38α encoding gene specifically in cardiac fibroblasts or myofibroblasts with 2 different tamoxifen-inducible Cre recombinase–expressing gene–targeted mouse lines. Mice were subjected to ischemic injury or chronic neurohumoral stimulation and monitored for survival, cardiac function, and fibrotic remodeling. Antithetically, mice with fibroblast-specific transgenic overexpression of activated mitogen-activated protein kinase kinase 6, a direct inducer of p38, were generated to investigate whether this pathway can directly drive myofibroblast formation and the cardiac fibrotic response. Results: In mice, loss of Mapk14 blocked cardiac fibroblast differentiation into myofibroblasts and ensuing fibrosis in response to ischemic injury or chronic neurohumoral stimulation. A similar inhibition of myofibroblast formation and healing was also observed in a dermal wounding model with deletion of Mapk14 . Transgenic mice with fibroblast-specific activation of mitogen-activated protein kinase kinase 6–p38 developed interstitial and perivascular fibrosis in the heart, lung, and kidney as a result of enhanced myofibroblast numbers. Mechanistic experiments show that p38 transduces cytokine and mechanical signals into myofibroblast differentiation through the transcription factor serum response factor and the signaling effector calcineurin. Conclusions: These findings suggest that signals from diverse modes of injury converge on p38α mitogen-activated protein kinase within the fibroblast to program the fibrotic response and myofibroblast formation in vivo, suggesting a novel therapeutic approach with p38 inhibitors for future clinical application.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Smad-dependent and Smad-independent pathways in TGF-β family signalling
Derynck, R., & Zhang, Y. E. (2003) · Nature · doi:10.1038/nature02006 · Cited by 5,373
Control of inositol 1,4,5-trisphosphate-induced Ca2+ release by cytosolic Ca2+
Bootman, M. D., Missiaen, L., Parys, J. B., De Smedt, H., & Casteels, R. (1995) · Biochemical Journal · doi:10.1042/bj3060445 · Cited by 5,120
Cellular and molecular mechanisms of fibrosis
Wynn, T. (2008) · The Journal of Pathology · doi:10.1002/path.2277 · Cited by 4,495
Baines, C. P., Kaiser, R. A., Purcell, N. H., Blair, N. S., Osinska, H., Hambleton, M. A., Brunskill, E. W., Sayen, M. R., Gottlieb, R. A., Dorn, G. W., et al. (2005) · Nature · doi:10.1038/nature03434 · Cited by 2,280
Self-citationHinz, B., Phan, S. H., Thannickal, V. J., Galli, A., Bochaton-Piallat, M.-L., & Gabbiani, G. (2007) · The American Journal of Pathology · doi:10.2353/ajpath.2007.070112 · Cited by 2,068
Revisiting Cardiac Cellular Composition
Pinto, A. R., Ilinykh, A., Ivey, M. J., Kuwabara, J. T., D’Antoni, M. L., Debuque, R., Chandran, A., Wang, L., Arora, K., Rosenthal, N. A., et al. (2016) · Circulation Research · doi:10.1161/circresaha.115.307778 · Cited by 1,400
Sudden death in hypertrophic cardiomyopathy: identification of high risk patients
Elliott, P. M., Poloniecki, J., Dickie, S., Sharma, S., Monserrat, L., Varnava, A., Mahon, N. G., & McKenna, W. J. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)01003-2 · Cited by 978
Genetic lineage tracing defines myofibroblast origin and function in the injured heart
Kanisicak, O., Khalil, H., Ivey, M. J., Karch, J., Maliken, B. D., Correll, R. N., Brody, M. J., J. Lin, S.-C., Aronow, B. J., Tallquist, M. D., et al. (2016) · Nature Communications · doi:10.1038/ncomms12260 · Cited by 892
Self-citationPrognostic Significance of Myocardial Fibrosis in Hypertrophic Cardiomyopathy
O'Hanlon, R., Grasso, A., Roughton, M., Moon, J. C., Clark, S., Wage, R., Webb, J., Kulkarni, M., Dawson, D., Sulaibeekh, L., et al. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.05.010 · Cited by 825
Calcineurin/NFAT Coupling Participates in Pathological, but not Physiological, Cardiac Hypertrophy
Wilkins, B. J., Dai, Y.-S., Bueno, O. F., Parsons, S. A., Xu, J., Plank, D. M., Jones, F., Kimball, T. R., & Molkentin, J. D. (2004) · Circulation Research · doi:10.1161/01.res.0000109415.17511.18 · Cited by 761
Self-citationThe myofibroblast: Paradigm for a mechanically active cell
Hinz, B. (2010) · Journal of Biomechanics · doi:10.1016/j.jbiomech.2009.09.020 · Cited by 698
Bruder, O., Wagner, A., Jensen, C. J., Schneider, S., Ong, P., Kispert, E.-M., Nassenstein, K., Schlosser, T., Sabin, G. V., Sechtem, U., et al. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.05.007 · Cited by 590
Acharya, A., Baek, S. T., Huang, G., Eskiocak, B., Goetsch, S., Sung, C. Y., Banfi, S., Sauer, M. F., Olsen, G. S., Duffield, J. S., et al. (2012) · Development · doi:10.1242/dev.079970 · Cited by 498
Oka, T., Xu, J., Kaiser, R. A., Melendez, J., Hambleton, M., Sargent, M. A., Lorts, A., Brunskill, E. W., Dorn, G. W., Conway, S. J., et al. (2007) · Circulation Research · doi:10.1161/circresaha.107.149047 · Cited by 494
Self-citationPeriostin is essential for cardiac healingafter acute myocardial infarction
Shimazaki, M., Nakamura, K., Kii, I., Kashima, T., Amizuka, N., Li, M., Saito, M., Fukuda, K., Nishiyama, T., Kitajima, S., et al. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20071297 · Cited by 461
Dobaczewski, M., Bujak, M., Li, N., Gonzalez-Quesada, C., Mendoza, L. H., Wang, X.-F., & Frangogiannis, N. G. (2010) · Circulation Research · doi:10.1161/circresaha.109.216101 · Cited by 385
Small, E. M., Thatcher, J. E., Sutherland, L. B., Kinoshita, H., Gerard, R. D., Richardson, J. A., DiMaio, J. M., Sadek, H., Kuwahara, K., & Olson, E. N. (2010) · Circulation Research · doi:10.1161/circresaha.110.223172 · Cited by 373
A TRPC6-Dependent Pathway for Myofibroblast Transdifferentiation and Wound Healing In Vivo
Davis, J., Burr, A. R., Davis, G. F., Birnbaumer, L., & Molkentin, J. D. (2012) · Developmental Cell · doi:10.1016/j.devcel.2012.08.017 · Cited by 358
Self-citationMyofibroblasts: Trust your heart and let fate decide
Davis, J., & Molkentin, J. D. (2014) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2013.10.019 · Cited by 345
Self-citationMechanical force regulation of myofibroblast differentiation in cardiac fibroblasts
Wang, J., Chen, H., Seth, A., & McCulloch, C. A. (2003) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00387.2003 · Cited by 270
Kaur, H., Takefuji, M., Ngai, C. Y., Carvalho, J., Bayer, J., Wietelmann, A., Poetsch, A., Hoelper, S., Conway, S. J., Möllmann, H., et al. (2016) · Circulation Research · doi:10.1161/circresaha.116.308643 · Cited by 259
Nishida, K., Yamaguchi, O., Hirotani, S., Hikoso, S., Higuchi, Y., Watanabe, T., Takeda, T., Osuka, S., Morita, T., Kondoh, G., et al. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.24.10611-10620.2004 · Cited by 238
Self-citationThe Role of p38α Mitogen-Activated Protein Kinase Activation in Renal Fibrosis
Stambe, C., Atkins, R. C., Tesch, G. H., Masaki, T., Schreiner, G. F., & Nikolic-Paterson, D. J. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000109669.23650.56 · Cited by 194
Myocyte Enhancer Factors 2A and 2C Induce Dilated Cardiomyopathy in Transgenic Mice
Xu, J., Gong, N. L., Bodi, I., Aronow, B. J., Backx, P. H., & Molkentin, J. D. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m510217200 · Cited by 190
Self-citationLiu, Y., Cseresnyés, Z., Randall, W. R., & Schneider, M. F. (2001) · The Journal of Cell Biology · doi:10.1083/jcb.200103020 · Cited by 182
Sandbo, N., & Dulin, N. (2011) · Translational Research · doi:10.1016/j.trsl.2011.05.004 · Cited by 179
Wang, H., Tibbitt, M. W., Langer, S. J., Leinwand, L. A., & Anseth, K. S. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1306369110 · Cited by 170
Efficient inducible Cre‐mediated recombination in Tcf21 cell lineages in the heart and kidney
Acharya, A., Baek, S. T., Banfi, S., Eskiocak, B., & Tallquist, M. D. (2011) · genesis · doi:10.1002/dvg.20750 · Cited by 167
Myofibroblasts and the extracellular matrix network in post-myocardial infarction cardiac remodeling
Ma, Y., de Castro Brás, L. E., Toba, H., Iyer, R. P., Hall, M. E., Winniford, M. D., Lange, R. A., Tyagi, S. C., & Lindsey, M. L. (2014) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-014-1463-9 · Cited by 162
Molecular networks underlying myofibroblast fate and fibrosis
Stempien‐Otero, A., Kim, D., & Davis, J. (2016) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2016.05.002 · Cited by 150
Self-citationp38 Inhibitors Prevent TGF-β–Induced Myofibroblast Transdifferentiation in Human Tenon Fibroblasts
Meyer-ter-Vehn, T., Gebhardt, S., Sebald, W., Buttmann, M., Grehn, F., Schlunck, G., & Knaus, P. (2006) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.05-0361 · Cited by 125
Kim, S. I., Kwak, J. H., Zachariah, M. S., He, Y., Wang, L., & Choi, M. E. (2007) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00485.2006 · Cited by 123
A p38 MAPK inhibitor, FR-167653, ameliorates murine bleomycin-induced pulmonary fibrosis
Matsuoka, H., Arai, T., Mori, M., Goya, S., Kida, H., Morishita, H., Fujiwara, H., Tachibana, I., Osaki, T., & Hayashi, S. (2002) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00187.2001 · Cited by 119
Davis, J., Salomonis, N., Ghearing, N., Lin, S. J., Kwong, J. Q., Mohan, A., Swanson, M. S., & Molkentin, J. D. (2015) · Nature Communications · doi:10.1038/ncomms10084 · Cited by 105
Self-citationWang, L., Ma, R., Flavell, R. A., & Choi, M. E. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m208573200 · Cited by 96
Role of ERK1/2 signaling in congenital valve malformations in Noonan syndrome
Krenz, M., Gulick, J. M., Osińska, H. E., Colbert, M. C., Molkentin, J. D., & Robbins, J. M. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0806556105 · Cited by 96
Self-citationTargeting cardiac fibroblasts to treat fibrosis of the heart: Focus on HDACs
Schuetze, K. B., McKinsey, T. A., & Long, C. S. (2014) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2014.02.015 · Cited by 83
Kyoi, S., OTANI, H., Matsuhisa, S., Akita, Y., Tatsumi, K., Enoki, C., Fujiwara, H., IMAMURA, H., Kamihata, H., & Iwasaka, T. (2005) · Cardiovascular Research · doi:10.1016/j.cardiores.2005.11.015 · Cited by 65
Vittal, R., Fisher, A. J., Gu, H., Mickler, E. A., Panitch, A., Lander, C., Cummings, O. W., Sandusky, G. E., & Wilkes, D. S. (2013) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2012-0389oc · Cited by 60
Kompa, A. R., See, F., Lewis, D. A., Adrahtas, A., Cantwell, D., Wang, B. H., & Krum, H. (2008) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.133546 · Cited by 58
P38α MAPK underlies muscular dystrophy and myofiber death through a Bax-dependent mechanism
Wissing, E. R., Boyer, J. G., Kwong, J. Q., Sargent, M. A., Karch, J. M., McNally, E. M., Otsu, K., & Molkentin, J. D. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu270 · Cited by 53
Self-citationFibrosis as a Therapeutic Target Post-Myocardial Infarction
See, F., Kompa, A. R., Martin, J. H., Lewis, D., & Krum, H. (2005) · Current Pharmaceutical Design · doi:10.2174/1381612053382098 · Cited by 45
Xu, L., Yates, C. C., Lockyer, P. P., Xie, L., Bevilacqua, A., He, J., Lander, C., Patterson, C., & Willis, M. S. (2014) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2014.09.011 · Cited by 42
Wilde, J. M., Gumucio, J. P., Grekin, J. A., Sarver, D. C., Noah, A. C., Ruehlmann, D. G., Davis, M. E., Bedi, A., & Mendias, C. L. (2016) · Journal of Shoulder and Elbow Surgery · doi:10.1016/j.jse.2016.01.035 · Cited by 34
Characterization of Cell Subpopulations Expressing Progenitor Cell Markers in Porcine Cardiac Valves
Wang, H., Sridhar, B. V., Leinwand, L. A., & Anseth, K. S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0069667 · Cited by 32
Cited by
Transforming growth factor–β in tissue fibrosis
Frangogiannis, N. G. (2020) · Journal of Experimental Medicine · doi:10.1084/jem.20190103 · Cited by 1,278
Frangogiannis, N. G. (2021) · Cardiovascular Research · doi:10.1093/cvr/cvaa324 · Cited by 1,229
Fibroblast-specific TGF-β–Smad2/3 signaling underlies cardiac fibrosis
Khalil, H., Kanisicak, O., Prasad, V., Correll, R. N., Fu, X., Schips, T., Vagnozzi, R. J., Liu, R., Huynh, T., Lee, S.-J., et al. (2017) · Journal of Clinical Investigation · doi:10.1172/jci94753 · Cited by 905
Self-citationCardiac fibrosis: Cell biological mechanisms, molecular pathways and therapeutic opportunities
Frangogiannis, N. G. (2019) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2018.07.001 · Cited by 841
Myofibroblasts and Fibrosis: Mitochondrial and Metabolic Control of Cellular Differentiation
Gibb, A. A., Lazaropoulos, M. P., & Elrod, J. W. (2020) · Circulation Research · doi:10.1161/circresaha.120.316958 · Cited by 434
Metadata
- Authors
- Molkentin, J. D., Bugg, D., Ghearing, N., Dorn, L. E., Kim, P., Sargent, M. A., Gunaje, J., Otsu, K., & Davis, J.
- Venue
- Circulation
- Published
- 2017-08-08
- Volume
- 136
- Issue
- 6
- Pages
- 549-561
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2597639984
- Cited by
- 283
- References
- 45
- FWCI
- 20.11
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.